Patient Financial News

David Michael Malone, my friend and mentor, elected to die with dignity on 24 November at the age of 71. The veteran scholar-diplomat—a former Canadian high commissioner to India—had been diagnosed with prostate cancer a couple of years ago and Alzheimer’s disease more recently.He was spared the pain but did not want to suffer the loss of memory and degradation of the quality of life that comes with Alzheimer’s. He invoked Canada’s right to die when he was still in control of his mental faculties and passed away a day after spending an enjoyable evening out with his close friends.As much as I will miss his long-distance friendship and sage advice, I was not unhappy to see him depart the way he did.

Subscribe to enjoy similar stories. MUMBAI: Danish drugmaker Novo Nordisk launched its blockbuster drug Ozempic in India on Friday, priced at ₹8,800 per monthfor a starting dose. The launch comes close on the heels of Wegovy, the company’s other injectable weight-loss drug, which entered the market in June.

Subscribe to enjoy similar stories. NEW DELHI : India is witnessing a significant surge in influenza cases, driven by the H3N2 subtype, clinically known to cause more severe infections and higher hospitalizations, according to the latest surveillance data from the country's premier medical research organization, the Indian Council of Medical Research (ICMR). Taking cognisance of the situation, Union health minister J.P.

Subscribe to enjoy similar stories. Health-tech providers have emerged as the only bright spot in India's $283-billion IT sector, with companies such as Sagility, Inventurus Knowledge Solutions (IKS) and Indegene recording steady growth despite a sluggish demand environment. Tier-1 information technology (IT) services providers, mid-caps, engineering research and development (ER&D) firms and health-tech companies reported an average sequential growth of 1.6%, 2.7%, 2.89%, and 4.2%, respectively, during the July-September quarter.

Subscribe to enjoy similar stories. New Delhi: India is moving to reduce its heavy reliance on imported diagnostic technology by fast-tracking commercialization of homegrown solutions.

Subscribe to enjoy similar stories. Despite being among the great scientific breakthroughs of all time, vaccines are under fire as top government officials cast doubts on their safety. But as doctors and vaccine deniers spar over the safety of vaccines, emerging evidence finds that some vaccines aren’t only good at preventing the disease or virus they target but also might have broader or even unrelated health benefits.

Subscribe to enjoy similar stories. NEW DELHI: India’s drug regulator, the Drugs Controller General of India (DCGI), plans to tighten rules on the sale and distribution of emergency contraceptive pills, including levonorgestrel formulations, sold under brand names such as Unwanted-72 and i-pill, and ulipristal pills sold as ella. The move, aimed at preventing habitual overuse and ensuring women have access to critical safety information, will require these pills to carry QR codes on their packaging, according to two officials and a document reviewed by Mint.

Subscribe to enjoy similar stories. MUCH OF THE art of medicine involves working out, through detailed questioning and physical examination, which disease a given patient has contracted. Far harder, but no less desirable, would be identifying which diseases a patient might develop in the future.

“We have to be patient. Trade pacts do not happen overnight. It is a careful and steady process. Things are analysed carefully,” an official said on the condition of anonymity, adding that a slight impact on demand in the US could be a little challenging. India has “emerged a winner” following the reciprocal tariffs imposed by the United States, officials said, pointing out that the country has a first mover advantage compared to its competitors owing to of the Bilateral Trade Agreement (BTA) that the two are negotiating and because Indian exporters are better positioned to deal with the additional US tariffs. They said the country will take all measures within the World Trade Organization (WTO) framework to check dumping of goods from countries such as China which have been slapped with steeper tariffs. “The government is there to protect domestic industry from any possibility of dumping of goods in such a situation,” the official added. While the US has imposed 26% reciprocal tariffs on India, it has levied 34% additional import duties on China. India is also likely to gain from the US-China trade war, according to officials.

«She (Natarajan) said the government should also listen to their (students and others) objections. And wait for the Supreme Court's ruling on the land issue too. We will hold consultations with all stakeholders and we should give patient hearing,» a senior Congress leader told PTI. Natarajan is expected to meet some civil society groups also on the issue. The Congress leader said the Kancha Gachibowli land belongs to the state government and the present dispensation fought in the courts and retained it. UoH sources told PTI that some student groups and some employees of the varsity are likely to meet Natarajan on Sunday.

University of Ottawa, said that patients incurring catastrophic costs are two to four times more likely to experience treatment failure. Therefore, mitigating treatment costs will not only benefit individuals, but also health systems and communities at large, they said. Tuberculosis is a bacterial disease that spreads through the air when an infected person coughs or sneezes. Symptoms include a persistent cough, chest pain, fever, fatigue, among others. Findings, published in the journal PLOS Global Public Health, also showed that costs were consistently higher among patients having drug resistant tuberculosis and those identified through 'passive case finding'. The researchers suggested that actively finding cases, along with improving access to tests for drug resistant tuberculosis, may help mitigate the burden of out-of-pocket expenditures incurred by patients.

Subscribe to enjoy similar stories. ANAESTHETICS THAT don’t put patients to sleep. Laxatives that fail to clear bowels.

Donald Trump presented a rosy assessment after the stock market dropped sharply Thursday over his tariffs, saying, «I think it's going very well.» «The markets are going to boom, the stock is going to boom, the country is going to boom,» he said when asked about the market as he left the White House to fly to one of his Florida golf clubs. The Dow Jones Industrial Average plunged over 1,600 points on Thursday, leading a global market selloff after President Trump’s sweeping tariff announcement triggered the sharpest shock since the COVID-19 pandemic. On Wednesday, Trump unveiled a minimum 10% tariff on imports, with significantly higher rates for goods from specific countries like China and members of the European Union. While the move rattled markets worldwide, Trump downplayed the reaction, saying it was expected. Comparing the U.S. to a sick patient needing surgery, he responded to questions about the worst stock market drop in years.

Donald Trump on Thursday said that the US economy would emerge «far stronger» even as markets went down globally after the reciprocal tariffs. Taking to social media platform Truth, Trump said, «The operation is over! The patient lived and is healing. The prognosis is that the patient will be far stronger, bigger, better and more resilient than ever before.» White House Press Secretary Karoline Leavitt also reassured US markets. «To anyone on Wall Street this morning, I would say, 'Trust in President Trump.' This is a president who is doubling down on his proven economic formula,» she said while speaking with CNN. She said the tariffs, which include 10 percent across the board levies on imports and steeper barriers on several countries including India, meant «the United States is no longer going to be cheated by foreign nations.»

Subscribe to enjoy similar stories. At 11:49 a.m. on July 18, North Korean hackers pounced on a major cryptocurrency exchange handling hundreds of millions of dollars.

Subscribe to enjoy similar stories. Wockhardt Ltd that built its name as a maker of generic drugs is shifting its focus in the US market to developing new antibiotics, turning away from generics and entering a space largely vacated by Big Pharma in recent years. The company is working on new antibiotics and has identified segments for a push into biosimilar drugs, chairman Habil Khorakiwala said, in the wake of promising results shown by Zaynich, an antibiotic it developed in-house.

Donald Trump’s tariffs. Some are confident that whatever is announced on Wednesday will not hurt them; others are genuinely uncertain how to manage if they can’t export to the US. The pharmaceutical industry — which is well known globally for churning out generic drugs that are the backbone of many countries’ health systems — should be particularly worried. Over 30% of Indian pharma exports go to the US, and it provides an even larger proportion of earnings. Trump has promised, in the past, that levies on pharma imports would begin at 25%, similar to what he imposed on cars recently. But the president seems to have walked that back more recently, perhaps because the administration is uncertain of the consequences of a sharp rise in the price of off-patent drugs.

cyberattack at Oracle as the hackers broke into the cloud computing company's computer systems and stole patient data, Bloomberg News reported on Friday, citing a person familiar with the matter. Earlier this month, the company alerted some healthcare customers that sometime after January 22, hackers accessed its servers and copied patient data to an outside location, the report said. The hackers stole patient data in an attempt to extort multiple medical providers in the United States, according to the report.